id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-295973-41jqgsv0	Singh, Awadhesh Kumar	Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries	2020-03-26		.txt	text/plain	3461	163	50	In this review article, we have systematically searched the medical data base until and collated all the available evidences that have emerged so far on the efficacy of chloroquine and hydroxychloroquine, in the treatment of patients with COVID19 , with or without diabetes and present a perspective on both these compounds. A Chinese study involving more than 100 patients of COVID-19 found chloroquine superior to the control group in reducing symptom duration, exacerbation of pneumonia including radiological improvement and promoting virus-negative seroconversion without any severe side effects [18] . The expert consensus from the Department of Science and Technology and Health Commission of Guangdong province published on 20th February (based on in vitro evidence and still unpublished clinical experience) chloroquine phosphate tablet at a dose of 500 mg twice per day for 10 days for patients diagnosed as mild, moderate and severe cases of SARS-CoV-2 pneumonia in the absence of contraindication to the drug [21] .	./cache/cord-295973-41jqgsv0.txt	./txt/cord-295973-41jqgsv0.txt